Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril

G. Perani; C. Muggia; A. Martignoni; A. Bongarzoni; A. Radaelli; F. Testa; G. Finardi

Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril

G. Perani, C. Muggia, A. Martignoni, A. Bongarzoni, A. Radaelli, F. Testa, G. Finardi

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P

Original language	English
Pages (from-to)	635-639
Number of pages	5
Journal	Clinical Therapeutics
Volume	9
Issue number	6
Publication status	Published - 1987

ASJC Scopus subject areas

Pharmacology

Access to Document

Fingerprint Dive into the research topics of 'Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril'. Together they form a unique fingerprint.

Cite this

@article{460fdab83ea745b598a6d444ef3df39e,

title = "Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril",

abstract = "The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P",

author = "G. Perani and C. Muggia and A. Martignoni and A. Bongarzoni and A. Radaelli and F. Testa and G. Finardi",

year = "1987",

language = "English",

volume = "9",

pages = "635--639",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica Inc.",

number = "6",

}

TY - JOUR

T1 - Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril

AU - Perani, G.

AU - Muggia, C.

AU - Martignoni, A.

AU - Bongarzoni, A.

AU - Radaelli, A.

AU - Testa, F.

AU - Finardi, G.

PY - 1987

Y1 - 1987

N2 - The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P

AB - The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P

UR - http://www.scopus.com/inward/record.url?scp=0023635119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023635119&partnerID=8YFLogxK

M3 - Article

C2 - 2830973

AN - SCOPUS:0023635119

VL - 9

SP - 635

EP - 639

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 6

ER -